Literature DB >> 27003494

Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in Uganda.

Agnes N Kiragga1, Elizabeth Nalintya, Bozena M Morawski, Joanita Kigozi, Benjamin J Park, Jonathan E Kaplan, David R Boulware, David B Meya, Yukari C Manabe.   

Abstract

INTRODUCTION: Improving HIV outcomes among severely immunocompromised HIV-infected persons who have increased morbidity and mortality remains an important issue in sub-Saharan Africa. We sought to evaluate the impact of targeted clinic-based nurse care on antiretroviral therapy (ART) initiation and retention among severely immunocompromised HIV-infected persons.
METHODS: The study included ART-naive patients with CD4 counts <100 cells per microliter registered in seven urban clinics in Kampala, Uganda. Data were retrospectively collected on patients enrolled from July to December 2011 (routine care cohort). Between July 2012 and September 2013, 1 additional nurse per clinic was hired (nurse counselor cohort) to identify new patients, expedite ART initiation, and trace those who were lost to follow-up. We compared time to ART initiation and 6-month retention in care between cohorts and used a generalized linear model to estimate the relative risk of retention.
RESULTS: The study included 258 patients in the routine care cohort and 593 in the nurse counselor cohort. The proportion of patients who initiated ART increased from 190 (73.6%) in the routine care cohort to 506 (85.3%) in the nurse counselor cohort (P < 0.001). At 6 months, 62% of the routine care cohort were retained in care versus 76% in the nurse counselor cohort (P = 0.001). A 21% increase in the likelihood of retention in the nurse counselor cohort (relative risk: 1.21, 95% CI: 1.09 to 1.34) compared with the routine care cohort was observed.
CONCLUSIONS: Implementation of targeted nurse-led care of severely immunocompromised HIV-infected patients in public outpatient health care facilities resulted in decreased time to ART initiation and increased retention.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27003494      PMCID: PMC4978777          DOI: 10.1097/QAI.0000000000001002

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  30 in total

1.  A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa.

Authors:  Elvin H Geng; David V Glidden; David R Bangsberg; Mwebesa Bosco Bwana; Nicholas Musinguzi; Denis Nash; John Z Metcalfe; Constantin T Yiannoutsos; Jeffrey N Martin; Maya L Petersen
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

2.  Benefits of task-shifting HIV care to nurses in terms of health-related quality of life in patients initiating antiretroviral therapy in rural district hospitals in Cameroon [Stratall Agence Nationale de Recherche sur le SIDA (ANRS) 12110/Ensemble pour une Solidarité Thérapeutique Hospitalière en Réseau (ESTHER) substudy].

Authors:  M Suzan-Monti; J Blanche; S Boyer; C Kouanfack; E Delaporte; R-C Bonono; P M Carrieri; C Protopopescu; C Laurent; B Spire
Journal:  HIV Med       Date:  2015-02-27       Impact factor: 3.180

3.  Toward an AIDS-free generation.

Authors:  Anthony S Fauci; Gregory K Folkers
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

4.  Retention in care: lessons relearned.

Authors:  Lucy Bradley-Springer
Journal:  J Assoc Nurses AIDS Care       Date:  2014-06-30       Impact factor: 1.354

Review 5.  Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review.

Authors:  Darshini Govindasamy; Nathan Ford; Katharina Kranzer
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

6.  Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.

Authors:  Sayoki Mfinanga; Duncan Chanda; Sokoine L Kivuyo; Lorna Guinness; Christian Bottomley; Victoria Simms; Carol Chijoka; Ayubu Masasi; Godfather Kimaro; Bernard Ngowi; Amos Kahwa; Peter Mwaba; Thomas S Harrison; Saidi Egwaga; Shabbar Jaffar
Journal:  Lancet       Date:  2015-03-10       Impact factor: 79.321

7.  Voucher incentives improve linkage to and retention in care among HIV-infected drug users in Chennai, India.

Authors:  Sunil Suhas Solomon; Aylur K Srikrishnan; Canjeevaram K Vasudevan; Santhanam Anand; Muniratnam Suresh Kumar; Pachamuthu Balakrishnan; Shruti H Mehta; Suniti Solomon; Gregory M Lucas
Journal:  Clin Infect Dis       Date:  2014-05-06       Impact factor: 9.079

8.  The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.

Authors:  Elena Losina; Ingrid V Bassett; Janet Giddy; Senica Chetty; Susan Regan; Rochelle P Walensky; Douglas Ross; Callie A Scott; Lauren M Uhler; Jeffrey N Katz; Helga Holst; Kenneth A Freedberg
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

9.  Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa.

Authors:  Matthias Egger; Ben D Spycher; John Sidle; Ralf Weigel; Elvin H Geng; Matthew P Fox; Patrick MacPhail; Gilles van Cutsem; Eugène Messou; Robin Wood; Denis Nash; Margaret Pascoe; Diana Dickinson; Jean-François Etard; James A McIntyre; Martin W G Brinkhof
Journal:  PLoS Med       Date:  2011-01-18       Impact factor: 11.069

Review 10.  Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.

Authors:  Katharina Kranzer; Darshini Govindasamy; Nathan Ford; Victoria Johnston; Stephen D Lawn
Journal:  J Int AIDS Soc       Date:  2012-11-19       Impact factor: 5.396

View more
  6 in total

1.  A Systematic Review of Linkage-to-Care and Antiretroviral Initiation Implementation Strategies in Low- and Middle-Income Countries Across Sub-Saharan Africa.

Authors:  Nneoma E Okonkwo; Alexander Blum; Nikita Viswasam; Elizabeth Hahn; Sofia Ryan; Gnilane Turpin; Carrie E Lyons; Stefan Baral; Bhakti Hansoti
Journal:  AIDS Behav       Date:  2022-01-28

Review 2.  Specification of implementation interventions to address the cascade of HIV care and treatment in resource-limited settings: a systematic review.

Authors:  Matthew D Hickey; Thomas A Odeny; Maya Petersen; Torsten B Neilands; Nancy Padian; Nathan Ford; Zachary Matthay; David Hoos; Meg Doherty; Chris Beryer; Stefan Baral; Elvin H Geng
Journal:  Implement Sci       Date:  2017-08-08       Impact factor: 7.327

3.  Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.

Authors:  David B Meya; Agnes N Kiragga; Elizabeth Nalintya; Bozena M Morawski; Radha Rajasingham; Benjamin J Park; Anthony Mubiru; Jonathan E Kaplan; Yukari C Manabe; David R Boulware
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

4.  Interventions to improve early retention of patients in antiretroviral therapy programmes in sub-Saharan Africa: A systematic review.

Authors:  Samuel Muhula; John Gachohi; Yeri Kombe; Simon Karanja
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

5.  Increased reengagement of out-of-care HIV patients using Lost & Found, a clinic-based intervention.

Authors:  Blake Linthwaite; Nadine Kronfli; Ivan Marbaniang; Luciana Ruppenthal; David Lessard; Kim Engler; Bertrand Lebouché; Joseph Cox
Journal:  AIDS       Date:  2022-03-15       Impact factor: 4.177

6.  A type II implementation-effectiveness hybrid quasi-experimental pilot study of a clinical intervention to re-engage people living with HIV into care, 'Lost & Found': an implementation science protocol.

Authors:  Joseph Cox; Blake Linthwaite; Kim Engler; David Lessard; Bertrand Lebouché; Nadine Kronfli
Journal:  Pilot Feasibility Stud       Date:  2020-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.